Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -7.01 | 10.72 |
PEG Ratio (TTM) | -0.28 | 10.12 |
P/S Ratio (TTM) | 0.51 | 2.56 |
P/B Ratio (TTM) | 1.05 | 5.75 |
P/FCF Ratio (TTM) | 25.95 | 18.38 |
Price to 5YR AVG Earnings Ratio | -0.08 | 25.43 |
Price to 5YR AVG FCF Ratio | -9.42 | 20.39 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -10.42% | 7.51% |
ROE (TTM) | -14.89% | 25.15% |
Net Profit Margin (TTM) | -7.19% | 11.10% |
ROIC 5YR AVG | -33.45% | -24.11% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -6,853.89% | 44.97% | 2.89% |
Revenue | 4.89% | 139.92% | 521.39% |
Net Income | -6,904.45% | 18.99% | -17.09% |
Cash Flow | 348.10% | -17.84% | 15.53% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.74 | 1.97 |
Quick Ratio (TTM) | 1.73 | 1.49 |
D/E Ratio (TTM) | 0.19 | 2.02 |
Interest Coverage (TTM) | 218.78 | 13.49 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 4.57 |
LTL to 5YR AVG FCF | -0.95 | 1.08 |
Shares Outstanding Growth 5YR AVG | 40.49% | 3.98% |